Evidence map›Paper›PMID 30704319›Full record

ArticleNanotoxicology2019

miRNA-378a as a key regulator of cardiovascular health following engineered nanomaterial inhalation exposure.

Quincy A Hathaway, Andrya J Durr, Danielle L Shepherd, Mark V Pinti, Ashley N Brandebura, Cody E Nichols, Amina Kunovac, William T Goldsmith, Sherri A Friend, Alaeddin B Abukabda and 3 more

Open access · greenAbstract read
In one paragraph

Article in Nanotoxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. NNanotoxicology · 2023
    Article
  5. MiR-199a-3p promotes repair of myocardial infarction by targeting NACC2.International journal of clinical and experimental pathology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cardiovascular adaptations to particle inhalation exposure: molecular mechanisms of the toxicology.American journal of physiology. Heart and circulatory physiology · 2020
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Quincy A Hathawaya Division of Exercise Physiology , West Virginia University School of Medicine , Morgantown , WV , USA.
Andrya J Durra Division of Exercise Physiology , West Virginia University School of Medicine , Morgantown , WV , USA.
Danielle L Shepherda Division of Exercise Physiology , West Virginia University School of Medicine , Morgantown , WV , USA.
Mark V Pintia Division of Exercise Physiology , West Virginia University School of Medicine , Morgantown , WV , USA.
Ashley N Brandeburad Rockefeller Neuroscience Institute , West Virginia University School of Medicine , Morgantown , WV , USA.
Cody E Nicholsf Immunity, Inflammation, and Disease Laboratory , National Institute of Environmental Health Sciences , Research Triangle Park , NC , USA.
Amina Kunovaca Division of Exercise Physiology , West Virginia University School of Medicine , Morgantown , WV , USA.
William T Goldsmithc Toxicology Working Group , West Virginia University School of Medicine , Morgantown , WV , USA.
Sherri A Friendh CDC , National Institute for Occupational Safety and Health , Morgantown , WV , USA.
Alaeddin B Abukabdac Toxicology Working Group , West Virginia University School of Medicine , Morgantown , WV , USA.
Garrett K Finka Division of Exercise Physiology , West Virginia University School of Medicine , Morgantown , WV , USA.
Timothy R Nurkiewiczc Toxicology Working Group , West Virginia University School of Medicine , Morgantown , WV , USA.
John M Hollandera Division of Exercise Physiology , West Virginia University School of Medicine , Morgantown , WV , USA.
West Virginia University · USBioEnergetics (United States) · USBlanchette Rockefeller Neurosciences Institute · USNational Institute for Occupational Safety and Health · USNational Institute of Environmental Health Sciences · US

Funding

WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI Travis Salisbury · 2012 to 2026
$61.1M
Remote Microvascular Dysfunction After Particulate Matter ExposureR01ES015022 · NIEHS · WEST VIRGINIA UNIVERSITY · PI NURKIEWICZ, TIMOTHY R · 2007 to 2021
$4.9M
West Virginia Flow Cytometry Core FacilityP30GM103488 · NIGMS · WEST VIRGINIA UNIVERSITY · PI GIBSON, LAURA F. · 2012 to 2016
$4.8M
miRNA Regulation of the Mitochondrial GenomeR01HL128485 · NHLBI · WEST VIRGINIA UNIVERSITY · PI HOLLANDER, JOHN M · 2017 to 2019
$1.3M
Special Becton Dickinson Fortessa Flow CytometerS10OD016165 · OD · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2013 to 2013
$384k
American Heart Association-American Stroke Association 17PRE33660333NHLBI NIH HHS R01 HL128485NIEHS NIH HHS R01 ES015022NIGMS NIH HHS P20 GM103434NIGMS NIH HHS P30 GM103488NIH HHS S10 OD016165
6 · The paper itself

Abstract

Nano-titanium dioxide (nano-TiO

Indexed as

AnimalsCardiovascular Physiological PhenomenaEchocardiographyGene ExpressionHeartInhalation ExposureMiceMice, KnockoutMicroRNAsMitochondriaNanoparticlesTitaniumMicroRNAsMIRN378 microRNA, mouseTitaniumtitanium dioxideCardiovascularinhalation exposuremitochondria

Identifiers

PMID30704319
PMCPMC6629495
OpenAlexW2913713315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.